From the serum biomarker analysis, the levels of S100A8/A9, IP-10, IL-6, PDGF-AA, and PDGF-BB were increased in the SJS/TEN group; they may be potential markers that could differentiate between HC and those with SJS/TEN. This evidence concerns the gene S100A8 and toxic epidermal necrolysis.